Clinical Trials Browser

Carcinoma, Hepatocellular × Hyperthermia, Induced × 90 days × Clear all

NCT07062055 2026-05-08

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular